Shyam Prabhakaran to Platelet Aggregation Inhibitors
This is a "connection" page, showing publications Shyam Prabhakaran has written about Platelet Aggregation Inhibitors.
Connection Strength
2.487
-
Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review. JAMA. 2021 Mar 16; 325(11):1088-1098.
Score: 0.720
-
Challenges in the Medical Management of Symptomatic Intracranial Stenosis in an Urban Setting. Stroke. 2017 08; 48(8):2158-2163.
Score: 0.557
-
Efficacy and safety of novel oral anticoagulants in patients with cervical artery dissections. Cerebrovasc Dis. 2014; 38(4):247-53.
Score: 0.464
-
Risk Factors Control and Early Recurrent Cerebral Infarction in Patients with Symptomatic Intracranial Atherosclerotic Disease. J Stroke Cerebrovasc Dis. 2021 Sep; 30(9):105914.
Score: 0.184
-
Is There Equipoise Regarding the Optimal Medical Treatment of Patients with Asymptomatic White Matter Hyperintensities? J Stroke Cerebrovasc Dis. 2019 Nov; 28(11):104371.
Score: 0.162
-
Medication History versus Point-of-Care Platelet Activity Testing in Patients with Intracerebral Hemorrhage. J Stroke Cerebrovasc Dis. 2018 May; 27(5):1167-1173.
Score: 0.144
-
Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting. AJNR Am J Neuroradiol. 2008 Feb; 29(2):281-5.
Score: 0.071
-
Experimental treatments for acute ischaemic stroke. Lancet. 2007 Jan 27; 369(9558):331-41.
Score: 0.068
-
Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study. Cerebrovasc Dis. 2006; 22(1):4-12.
Score: 0.064
-
Vulnerable and Stabilized States After Cerebral Ischemic Events: Implications of Kinetic Modeling in the SOCRATES, POINT, and THALES Trials. Neurology. 2023 Nov 27; 101(22):e2205-e2214.
Score: 0.054